Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
China NT Pharma Group Co., Ltd. ( (HK:1011) ) has shared an update.
China NT Pharma Group Co., Ltd. has announced a potential acquisition and disposal involving its associate, Beijing Kangchen Biotechnology Company Limited. The proposed plan involves splitting the assets of the associate to protect shareholder interests, with the intention of dissolving the associate relationship and allowing independent operations. This move could impact the company’s operations by potentially expanding its asset base and altering its industry positioning, depending on the outcome of negotiations with Konruns Pharmaceutical.
More about China NT Pharma Group Co., Ltd.
China NT Pharma Group Co., Ltd. operates in the pharmaceutical industry, focusing on the development, manufacturing, and distribution of pharmaceutical products. The company is involved in the production of various medical treatments and has a market focus on both domestic and international pharmaceutical sectors.
Average Trading Volume: 1,322,741
Technical Sentiment Signal: Hold
Current Market Cap: HK$229.2M
For detailed information about 1011 stock, go to TipRanks’ Stock Analysis page.